BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 23141215)

  • 21. Oestrogen and progesterone receptor expression in subtypes of canine mammary tumours in intact and ovariectomised dogs.
    Mainenti M; Rasotto R; Carnier P; Zappulli V
    Vet J; 2014 Oct; 202(1):62-8. PubMed ID: 24980810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and prognostic value of c-met in canine mammary tumours.
    Chen YC; Chen YY; Liao JW; Chang SC
    Vet Comp Oncol; 2018 Dec; 16(4):670-676. PubMed ID: 30129270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proliferative activity, apoptosis and expression of oestrogen receptor and Bcl-2 oncoprotein in canine mammary gland tumours.
    Yang WY; Liu CH; Chang CJ; Lee CC; Chang KJ; Lin CT
    J Comp Pathol; 2006 Jan; 134(1):70-9. PubMed ID: 16423573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Caveolin-1 in diagnosis and prognosis of canine mammary tumours: comparison of evaluation systems.
    Pereira PD; Lopes CC; Matos AJ; Cortez PP; Gärtner F; Medeiros R; Lopes C
    J Comp Pathol; 2010; 143(2-3):87-93. PubMed ID: 20153868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. E-cadherin immunohistochemical expression in mammary gland neoplasms in bitches.
    Rodo A; Malicka E
    Pol J Vet Sci; 2008; 11(1):47-54. PubMed ID: 18540208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of CD44 adhesion factor in canine mammary carcinomas.
    Madrazo J; García-Fernández RA; García-Iglesias MJ; Durán AJ; Espinosa J; Pérez-Martínez C
    Vet J; 2009 Jun; 180(3):371-6. PubMed ID: 18299241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of HER-2 in feline invasive mammary carcinomas: an immunohistochemical survey and evaluation of its prognostic potential.
    Millanta F; Calandrella M; Citi S; Della Santa D; Poli A
    Vet Pathol; 2005 Jan; 42(1):30-4. PubMed ID: 15657269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphangiogenesis in canine mammary tumours: a morphometric and prognostic study.
    Sleeckx N; Van Brantegem L; Van den Eynden G; Fransen E; Casteleyn C; Van Cruchten S; Veldhuis Kroeze E; Van Ginneken C
    J Comp Pathol; 2014; 150(2-3):184-93. PubMed ID: 24225342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical evaluation of STAT3-p-tyr705 expression in feline mammary gland tumours and correlation with histologic grade.
    Petterino C; Ratto A; Podestà G; Drigo M; Pellegrino C
    Res Vet Sci; 2007 Apr; 82(2):218-24. PubMed ID: 16934302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decorin concentrations in canine normal and neoplastic mammary gland tissues.
    Szczubiał M; Kankofer M; Wawrzykowski J; Dąbrowski R; Łopuszyński W; Bochniarz M; Brodzki P
    Reprod Domest Anim; 2020 Oct; 55(10):1404-1410. PubMed ID: 33470009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p63: a novel myoepithelial cell marker in canine mammary tissues.
    Gama A; Alves A; Gartner F; Schmitt F
    Vet Pathol; 2003 Jul; 40(4):412-20. PubMed ID: 12824513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mucin 6 and Tn antigen expression in canine mammary tumours: correlation with pathological features.
    Tavares C; de Oliveira JT; Lopes C; Carvalheira J; Matos AJ; Rutteman G; Reis CA; Gärtner F
    J Comp Pathol; 2012 Nov; 147(4):410-8. PubMed ID: 22595635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible role of Snail expression as a prognostic factor in canine mammary neoplasia.
    Im KS; Kim JH; Kim NH; Yu CH; Hur TY; Sur JH
    J Comp Pathol; 2012; 147(2-3):121-8. PubMed ID: 22297072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Androgen receptor expression in normal, hyperplastic and neoplastic hepatoid glands in the dog.
    Pisani G; Millanta F; Lorenzi D; Vannozzi I; Poli A
    Res Vet Sci; 2006 Oct; 81(2):231-6. PubMed ID: 16427103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased presence of stromal myofibroblasts and tenascin-C with malignant progression in canine mammary tumors.
    Yoshimura H; Michishita M; Ohkusu-Tsukada K; Takahashi K
    Vet Pathol; 2011 Jan; 48(1):313-21. PubMed ID: 20571146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of Cox-1 and Cox-2 in canine mammary tumours.
    Queiroga FL; Alves A; Pires I; Lopes C
    J Comp Pathol; 2007; 136(2-3):177-85. PubMed ID: 17416236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of tissue factor in canine mammary tumours and correlation with grade, stage and markers of haemostasis and inflammation.
    Andreasen EB; Nielsen OL; Tranholm M; Knudsen T; Kristensen AT
    Vet Comp Oncol; 2016 Jun; 14(2):191-201. PubMed ID: 24674618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression.
    Pinho SS; Matos AJ; Lopes C; Marcos NT; Carvalheira J; Reis CA; Gärtner F
    BMC Cancer; 2007 Jul; 7():124. PubMed ID: 17617904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell proliferation in feline normal, hyperplastic and neoplastic mammary tissue--an immunohistochemical study.
    Dias Pereira P; Carvalheira J; Gärtner F
    Vet J; 2004 Sep; 168(2):180-5. PubMed ID: 15301767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metallothionein expression in canine and feline mammary and melanotic tumours.
    Dincer Z; Jasani B; Haywood S; Mullins JE; Fuentealba IC
    J Comp Pathol; 2001; 125(2-3):130-6. PubMed ID: 11578128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.